Marian Sorin Paveliu
Overview
Explore the profile of Marian Sorin Paveliu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jakubowski S, Kawalec P, Holko P, Kowalska-Bobko I, Kamusheva M, Petrova G, et al.
Front Pharmacol
. 2024 Mar;
15:1369178.
PMID: 38523639
The aim of this study was to characterize the reimbursement policy for orphan drugs (ODs) in Central and Eastern European (CEE) countries in relation to the availability and impact of...
2.
Olariu E, Caplescu R, Vale L, Niculescu-Aron I, Oluboyede Y, Paveliu M
Health Qual Life Outcomes
. 2023 Jul;
21(1):80.
PMID: 37507760
Background: The majority of patient reported outcome measures (PROMs) don't have population norms in Romania. This is the case with the EQ-5D as well. Therefore, we aimed to estimate population...
3.
Olariu E, Mohammed W, Oluboyede Y, Caplescu R, Niculescu-Aron I, Paveliu M, et al.
Eur J Health Econ
. 2022 Jun;
24(3):399-412.
PMID: 35688994
Objective: We aimed to develop an EQ-5D-5L value set for Romania. Methods: In line with the EuroQoL standardized valuation protocol, computer-assisted interviews were conducted face-to-face in a representative sample in...
4.
Paveliu M, Olariu E, Caplescu R, Oluboyede Y, Niculescu-Aron I, Ernu S, et al.
Int J Environ Res Public Health
. 2021 Jul;
18(14).
PMID: 34299864
Objective: To provide health-related quality of life (HRQoL) data to support health technology assessment (HTA) and reimbursement decisions in Romania, by developing a country-specific value set for the EQ-5D-3L questionnaire....
5.
Malinowski K, Kawalec P, Trabka W, Sowada C, Petrova G, Manova M, et al.
Orphanet J Rare Dis
. 2020 Oct;
15(1):277.
PMID: 33032634
Background: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was...
6.
Olariu E, Paveliu M, Baican E, Oluboyede Y, Vale L, Niculescu-Aron I
BMJ Open
. 2019 Aug;
9(8):e029067.
PMID: 31427330
Introduction: The importance of health-related quality of life (HRQoL) is increasing and many healthcare authorities recommend the use of measures that account for both mortality and morbidity. This study will...
7.
Malinowski K, Kawalec P, Trabka W, Czech M, Petrova G, Manova M, et al.
Front Pharmacol
. 2019 May;
10:487.
PMID: 31139080
Background: Reimbursement policies influence access of patients to orphan drugs in the European countries. Objectives: To provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making...
8.
Paveliu M, Bengea-Luculescu S, Toma M, Paveliu S
Maedica (Bucur)
. 2013 Sep;
8(1):17-25.
PMID: 24023593
Unlabelled: Aim: The purpose of our study was to investigate and to assess the perceptions of Romanian doctors towards adverse drug reactions (ADRs) reporting. Method: A questionnaire with 20 items...
9.
Paveliu M, Bengea S, Paveliu F
Maedica (Bucur)
. 2011 Oct;
6(1):52-8.
PMID: 21977191
Doctors accuse individual variability or lack of quality of generic drugs for adverse reactions or lack of efficacy. The variability of effect of generic substitution, although accepted by clinicians as...